Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Sees Large Dec
Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Sees Large Decrease in Short Interest
Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Free Report) was the target of a significant drop in short interest during the month of June. As of June 30th, there was short interest totalling 3,790,000 shares, a drop of 14.1% from the June 15th total of 4,410,000 shares. Based on an average daily trading volume, of 533,300 […]
Related Keywords
United States, Stifel Nicolaus, Dennis Leo Walsh, Franklin Stuart Friedman, Sg Americas Securities, Exchange Traded Concepts, Geode Capital Management, Deciphera Pharmaceuticals Inc, Deciphera Pharmaceuticals, News Ratings For Deciphera Pharmaceuticals Daily, Squarepoint Ops, Deciphera Pharmaceuticals Company Profile, Securities Exchange Commission, Institutional Investors Weigh In On Deciphera Pharmaceuticals, Deciphera Pharmaceuticals Trading, Nasdaq, Get Free Report, Director Dennis Leo Walsh, Exchange Commission, Director Franklin Stuart Friedman, Traded Concepts, Street Group, Capital Management, Deciphera Pharmaceuticals Daily, Nasdaq Dcph, Dcph, Medical, Stocks, Options, Put, Call,